Keyphrases
Tumor
100%
Brain Tumor
100%
SPECT-CT
100%
C-X-C Chemokine Receptor Type 4 (CXCR4)
100%
Tumor Xenograft
100%
CXCR4 Expression
100%
Immunoimaging
100%
125I
66%
Monoclonal Antibody
33%
Imaging Studies
33%
Expression Level
33%
After Injection
33%
Biodistribution Studies
33%
Uptake Ratio
33%
Flow Cytometry
16%
Prostate
16%
Breast
16%
Metastasis
16%
Flow Cytometric Analysis
16%
Specific Radioactivity
16%
Fold Increase
16%
Tumor Metastasis
16%
Tumor Growth
16%
Tumor Uptake
16%
Xenograft
16%
Inoculum
16%
Tumor Development
16%
Predictive Marker
16%
Radio
16%
Chemokine Ligand 12 (CXCL12)
16%
In Vivo Imaging
16%
Metastatic Potential
16%
Hypoxic Tumor Microenvironment
16%
Neoplastic Tissue
16%
Percentage Yield
16%
Severe Combined Immunodeficient Mice
16%
Ex Vivo Biodistribution
16%
Muscle Uptake
16%
Medicine and Dentistry
Neoplasm
100%
Single Photon Emission Computed Tomography-Computed Tomography
100%
Brain Tumor
100%
Tumor Xenograft
100%
Iodine 125
50%
U87
37%
Flow Cytometry
25%
Metastatic Carcinoma
25%
Monoclonal Antibody
25%
Biodistribution
25%
Experimental Brain Tumor
25%
Malignant Neoplasm
12%
Xenograft
12%
SCID Mouse
12%
Ex Vivo
12%
Predictive Marker
12%
Chemokine Receptor
12%
Tumor Microenvironment
12%
Metastasis Potential
12%
Growth, Development and Aging
12%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Brain Tumor
100%
Iodine-125
50%
Biodistribution
25%
Monoclonal Antibody
25%
Flow Cytometry
25%
Experimental Brain Tumor
25%
Malignant Neoplasm
12%
SCID Mouse
12%
Tumor Microenvironment
12%
Metastasis Potential
12%
Chemokine Receptor
12%
Immunology and Microbiology
Xenograft
100%
CXCR4
100%
Single Photon Emission Computed Tomography-Computed Tomography
100%
Iodine-125
36%
Monoclonal Antibody
18%
Surface Property
9%
SCID Mouse
9%
Growth, Development and Aging
9%
Chemokine Receptor
9%
Inoculum
9%